Infinity stock back on upswing after two-month tumble

Infinity Pharmaceuticals Inc. (Nasdaq:INFI) was up 12 percent Tuesday as investors buy stock following what one analyst called an “overreaction” to data released earlier this month on the Cambridge biotech’s potential treatment for blood cancer...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.